rs1040311

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000500.9(CYP21A2):​c.550-8T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0167 in 1,541,382 control chromosomes in the GnomAD database, including 1,519 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 160 hom., cov: 31)
Exomes 𝑓: 0.014 ( 1359 hom. )

Consequence

CYP21A2
NM_000500.9 splice_region, intron

Scores

2
Splicing: ADA: 0.00006899
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.602

Publications

3 publications found
Variant links:
Genes affected
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CYP21A2 Gene-Disease associations (from GenCC):
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 6-32039538-T-C is Benign according to our data. Variant chr6-32039538-T-C is described in ClinVar as Benign. ClinVar VariationId is 256295.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 160 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP21A2NM_000500.9 linkc.550-8T>C splice_region_variant, intron_variant Intron 4 of 9 ENST00000644719.2 NP_000491.4
CYP21A2NM_001128590.4 linkc.460-8T>C splice_region_variant, intron_variant Intron 3 of 8 NP_001122062.3
CYP21A2NM_001368143.2 linkc.145-8T>C splice_region_variant, intron_variant Intron 4 of 9 NP_001355072.1
CYP21A2NM_001368144.2 linkc.145-8T>C splice_region_variant, intron_variant Intron 3 of 8 NP_001355073.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP21A2ENST00000644719.2 linkc.550-8T>C splice_region_variant, intron_variant Intron 4 of 9 NM_000500.9 ENSP00000496625.1

Frequencies

GnomAD3 genomes
AF:
0.0385
AC:
5672
AN:
147230
Hom.:
161
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0363
Gnomad AMI
AF:
0.0674
Gnomad AMR
AF:
0.0346
Gnomad ASJ
AF:
0.00870
Gnomad EAS
AF:
0.0338
Gnomad SAS
AF:
0.0234
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.0478
Gnomad NFE
AF:
0.0320
Gnomad OTH
AF:
0.0337
GnomAD2 exomes
AF:
0.0117
AC:
2426
AN:
206788
AF XY:
0.0110
show subpopulations
Gnomad AFR exome
AF:
0.0205
Gnomad AMR exome
AF:
0.0141
Gnomad ASJ exome
AF:
0.00258
Gnomad EAS exome
AF:
0.0301
Gnomad FIN exome
AF:
0.0133
Gnomad NFE exome
AF:
0.00825
Gnomad OTH exome
AF:
0.0121
GnomAD4 exome
AF:
0.0144
AC:
20021
AN:
1394040
Hom.:
1359
Cov.:
57
AF XY:
0.0147
AC XY:
10150
AN XY:
691804
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0194
AC:
621
AN:
31994
American (AMR)
AF:
0.0195
AC:
758
AN:
38966
Ashkenazi Jewish (ASJ)
AF:
0.00646
AC:
165
AN:
25554
East Asian (EAS)
AF:
0.0156
AC:
594
AN:
38046
South Asian (SAS)
AF:
0.0191
AC:
1559
AN:
81782
European-Finnish (FIN)
AF:
0.0865
AC:
4281
AN:
49472
Middle Eastern (MID)
AF:
0.00755
AC:
43
AN:
5694
European-Non Finnish (NFE)
AF:
0.0104
AC:
11033
AN:
1064388
Other (OTH)
AF:
0.0166
AC:
967
AN:
58144
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.304
Heterozygous variant carriers
0
1318
2636
3955
5273
6591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0385
AC:
5675
AN:
147342
Hom.:
160
Cov.:
31
AF XY:
0.0410
AC XY:
2941
AN XY:
71788
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0361
AC:
1459
AN:
40360
American (AMR)
AF:
0.0346
AC:
503
AN:
14552
Ashkenazi Jewish (ASJ)
AF:
0.00870
AC:
30
AN:
3448
East Asian (EAS)
AF:
0.0339
AC:
170
AN:
5016
South Asian (SAS)
AF:
0.0238
AC:
112
AN:
4700
European-Finnish (FIN)
AF:
0.118
AC:
1133
AN:
9612
Middle Eastern (MID)
AF:
0.0548
AC:
16
AN:
292
European-Non Finnish (NFE)
AF:
0.0320
AC:
2125
AN:
66444
Other (OTH)
AF:
0.0333
AC:
68
AN:
2042
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.318
Heterozygous variant carriers
0
313
626
939
1252
1565
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0312
Hom.:
17

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 23, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CYP21A2 c.550-8T>C alters a non-conserved nucleotide located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.012 in 206788 control chromosomes in the gnomAD database, including 217 homozygotes. The observed variant frequency is approximately 6-fold of the estimated maximal expected allele frequency for a pathogenic variant in CYP21A2 causing Congenital Adrenal Hyperplasia phenotype (0.002). To our knowledge, no occurrence of c.550-8T>C in individuals affected with Congenital Adrenal Hyperplasia and no experimental evidence demonstrating its impact on protein function have been reported. The following publications have been ascertained in the context of this evaluation (PMID: 1496017, 15110320). ClinVar contains an entry for this variant (Variation ID: 256295). Based on the evidence outlined above, the variant was classified as benign. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.7
DANN
Benign
0.57
PhyloP100
-0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000069
dbscSNV1_RF
Benign
0.018
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1040311; hg19: chr6-32007315; COSMIC: COSV64482182; COSMIC: COSV64482182; API